A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
NCT00042588
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Pneumonia
Sepsis
Interventions
DRUG:
Recombinant Chimeric Monoclonal Antibody
Sponsor
ICOS Corporation